Delivery Order SPE2DB24D2205-SPE2DB26FDSNR
Award Date 10/20/25
Potential Completion Date 10/21/25
Potential Value $41K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of HUMIRA (adalimumab) pen injections at 40 mg/0.4 mL. This firm fixed-price delivery order, valued at $27,237.04, represents a non-competitive award issued under an existing indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL pen injections, valued at $46,099.45. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of June 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,108.54 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mL on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $73,860.62 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) PEN 40 mg/0.4 mL auto-injectors under a firm fixed-price contract type. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025, with performance to occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued without a set-aside designation, indicating the award was...
- The Defense Logistics Agency awarded a delivery order valued at $9,063.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 5, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for HUMIRA Pen 40 mg/0.8 mL, valued at $1,574.50 under a firm fixed-price contract. The award was made on June 25, 2025, with an ultimate completion date of June 26, 2025. This non-set-aside contract is a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance of this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,868.90 to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) 40 mg/0.4 mL pen injectors. The contract is a firm fixed-price delivery order with no set-aside designation, issued on April 24, 2025, with an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,411.86 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable pharmaceutical product used for treating inflammatory conditions. This firm fixed-price delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at approximately $26,000 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) PEN 40 mg/0.4 mL auto-injectors. This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $37,698.62 to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL, a biologic pharmaceutical used to treat autoimmune conditions. This firm fixed-price delivery order was competitively awarded without set-aside designation and has an ultimate completion date of May 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...